Lilly Agrees To Cap Insulin Costs At $35 In Minnesota Settlement Agreement
NEWARK, N.J. — Eli Lilly and Co. has agreed to make its insulin products available to consumers in Minnesota for no more than $35 for a monthly subscription as part of...To view the full article, register now.
Already a subscriber? Click here to view full article